Dinalo, Mylyn .
HRN: 21-10-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFUROXIME 500MG (TAB)
05/30/2023
06/06/2023
PO
1 Tab
BID
SP NSVD W Repair; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes